Why Stereotaxis, Inc.’s (STXS) Stock Is Down 8.22%
As of Wednesday, August 12, Stereotaxis, Inc.’s STXS share price has dipped by 8.22%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Commentary & Analysis
Why Stereotaxis, Inc.’s (STXS) Stock Is Up 6.39%
As of Tuesday, August 04, Stereotaxis, Inc.’s STXS share price has surged by 6.39%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Stereotaxis, Inc.’s (STXS) Stock Is Up 5.16%
As of Monday, August 03, Stereotaxis, Inc.’s STXS share price has surged by 5.16%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Stereotaxis, Inc.’s (STXS) Stock Is Down 5.26%
As of Friday, July 31, Stereotaxis, Inc.’s STXS share price has dipped by 5.26%, which has investors questioning if this is right time to buy.Michael Rose
Why Stereotaxis, Inc.’s (STXS) Stock Is Down 5.38%
As of Thursday, July 23, Stereotaxis, Inc.’s STXS share price has dipped by 5.38%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | STXS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $139.3 | $423.0 | 24% |
|
| Shares Out (Mil) | 100.0 | 41.5 | 62% |
|
| Institutional Ownership | 62.9% | 83.6% | 39% |
|
| Float (Mil) | 65.5 | 35.5 | 53% |
|
| Beta | 1.40 | 0.88 | 79% |
|
| Avg Daily Volume (000s) | 430 | 346 | 58% |
|
| Price Change (52-week) |
(49.6%) | 65.4% | 15% |
|
| Growth | STXS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 4.0% | 11.8% | 31% |
|
| Net Income (5yr) | (26.8%) | (5.8%) | 16% |
|
| EPS (5yr) | (18.0%) | 10.4% | 15 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (44.5%) | (15.5%) | 9% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.055) | ($0.210) | ($0.155) | |
| Month Ago EPS | ($0.047) | ($0.190) | ($0.127) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | ($0.047) | ($0.190) | ($0.127) | |
| Year/Year Chg | 10.0% | (16.7%) | na | |
| Financials | STXS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $30 | $119 | 16% |
|
| Net Income (TTM) (Mil) | ($22) | ($9) | 23% |
|
| EPS (TTM) | ($0.244) | ($0.400) | 32% |
|
| Operating Cash Flow (TTM) (Mil) | ($15) | ($3) | 17% |
|
| Net Cash Flow (TTM) (Mil) | $4 | $1 | 50% |
|
| Long-Term Debt (Q1) (Mil) | $5 | $23 | 24% |
|
| Enterprise Value (Q1) (Mil) | $138 | $376 | 23% |
|
| Valuation | STXS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 10.69 | 2.85 | 91% |
|
| P/E | na | 27.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | STXS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 55.6% | 58.5% | 68% |
|
| Net Margin | (74.2%) | (6.9%) | 9% |
|
| ROA | (46.1%) | (13.3%) | 12% |
|
| ROE | (325.9%) | (13.3%) | 3% |
|
| Liabilities to Assets | 68.6% | 46.0% | 64% |
|
| F-Score | 5 | 4 | 50% |
|
Stereotaxis, Inc. did not pass any screens on 9/4/2026.
